0001437749-15-012313.txt : 20150615 0001437749-15-012313.hdr.sgml : 20150615 20150615161828 ACCESSION NUMBER: 0001437749-15-012313 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150609 FILED AS OF DATE: 20150615 DATE AS OF CHANGE: 20150615 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Biota Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0000072444 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 591212264 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 2500 NORTHWINDS PARKWAY, SUITE 100 CITY: ALPHARETTA STATE: 2Q ZIP: 30009 BUSINESS PHONE: 301-770-3099 MAIL ADDRESS: STREET 1: 2500 NORTHWINDS PARKWAY, SUITE 100 CITY: ALPHARETTA STATE: 2Q ZIP: 30009 FORMER COMPANY: FORMER CONFORMED NAME: NABI BIOPHARMACEUTICALS DATE OF NAME CHANGE: 20100719 FORMER COMPANY: FORMER CONFORMED NAME: NABI BIOPHARMACEUTICALS DATE OF NAME CHANGE: 20020304 FORMER COMPANY: FORMER CONFORMED NAME: NABI /DE/ DATE OF NAME CHANGE: 19960405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fox James CENTRAL INDEX KEY: 0001500591 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-35285 FILM NUMBER: 15931417 MAIL ADDRESS: STREET 1: 5964 LA PLACE COURT CITY: CARLSBAD STATE: CA ZIP: 92008 4/A 1 rdgdoc.xml FORM 4/A X0306 4/A 2015-06-09 2015-06-11 0000072444 Biota Pharmaceuticals, Inc. BOTA 0001500591 Fox James 2500 NORTHWINDS PARKWAY STE 100 ALPHARETTA GA 30009 1 Common stock 2015-06-10 4 P 0 70000 2.03 A 100614 I Penashe Holdings Pty Ltd. Common stock 8700 D Mr. Fox is an executive director of Penashe Holdings Propriety Limited and may be deemed to have beneficial ownership of these securities to the extent of any indirect pecuniary interest in his distributive shares therein. The original Form 4 report filed on June 11, 2015 incorrectly reported the purchase date and price of the purchase and excluded the direct holdings of the reporting person. /s/ Peter Azzarello attorney-in-fact for James Fox 2015-06-15